Cargando…
Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma
To investigate the clinical significance of circulating angiogenic factors, especially in association with early relapse of osteosarcoma, we quantified pre-therapeutic levels of vascular endothelial growth factor, basic fibroblast growth factor and placenta growth factor in the sera of 16 patients w...
Autores principales: | Kaya, M, Wada, T, Kawaguchi, S, Nagoya, S, Yamashita, T, Abe, Y, Hiraga, H, Isu, K, Shindoh, M, Higashino, F, Okada, F, Tada, M, Yamawaki, S, Ishii, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364146/ https://www.ncbi.nlm.nih.gov/pubmed/11953816 http://dx.doi.org/10.1038/sj.bjc.6600201 |
Ejemplares similares
-
Detection of Bone‐type Alkaline Phosphatase by Monoclonal Antibodies Reacting with Human Osteosarcoma‐associated Antigen
por: Nagoya, Satoshi, et al.
Publicado: (1991) -
TNP-470 Suppresses the Tumorigenicity of HT1080 Fibrosarcoma Tumor
Through the Inhibition of VEGF Secretion From the Tumor Cells
por: Kaya, Mitsunori, et al.
Publicado: (2001) -
HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
por: Tsukahara, Tomohide, et al.
Publicado: (2009) -
Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients
por: Dong-ju, Zhao, et al.
Publicado: (2014) -
Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility
por: Hu, Yuan-Yuan, et al.
Publicado: (2016)